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Abstract
Bacterial infection is a serious medical problem leading to implant failure. The current antibiotic 
based therapies rise concerns due to bacterial resistance. The family of antimicrobial peptides 
(AMP) is one of the promising candidates as local therapy agents due to their broad-spectrum 
activity. Despite AMPs receive increasing attention to treat infection, their effective delivery to the 
implantation site has been limited. Here, we developed an engineered dual functional peptide 
which delivers AMP as a biomolecular therapeutic agent onto calcium phosphate deposited 
nanotubular titanium surfaces. Dual functionality of the peptide was achieved by combining a 
hydroxyapatite binding peptide-1 (HABP1) with an AMP using a flexible linker. HABP 
functionality of the peptide provided a self-coating property onto the nano-topographies that are 
designed to improve osteointegration capability, while AMP offered an antimicrobial protection 
onto the implant surface. We successfully deposited calcium phosphate minerals on nanotubular 
titanium oxide surface using pulse electrochemical deposition (PECD) and characterized the 
minerals by XRD, FT-IR, FE-SEM. Antimicrobial activity of the engineered peptide was tested 
*Corresponding Author: Candan Tamerler, PhD, Wesley G. Cramer Professor, Core Director, Biomaterials and Tissue Engineering, 
Bioengineering Program, Director, Biomimetic Materials, Institute for Bioengineering Research, Department of Mechanical 
Engineering, University of Kansas, 1530 W, 15th St, Learned Hall, Lawrence, KS-66047, USA. ctamerler@ku.edu, Phone: 
785-864-2984. 
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
HHS Public Access
Author manuscript
Mater Sci Eng C Mater Biol Appl. Author manuscript; available in PMC 2020 June 19.
Published in final edited form as:
Mater Sci Eng C Mater Biol Appl. 2019 January 01; 94: 333–343. doi:10.1016/j.msec.2018.09.030.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
against S. mutans (gram- positive) and E. coli (gram-negative) both in solution and on the Ca-P 
coated nanotubular titanium surface. In solution activity of AMP and dual functional peptide have 
the same Minimum Inhibitory Concentration (MIC) (32 mg/mL) against E.coli. The peptide also 
resulted in the reduction of the number of bacteria both for E.coli and S.mutans compare to control 
groups. Antimicrobial features of dual functional peptides are strongly correlated with their 
structures suggesting tunability in design through linkers regions. The dual-function peptide offers 
single-step solution for implant surface functionalization that could be applicable to any implant 
surface having different topographies.
Keywords
Implant infections; hydroxyapatite-binding peptide; calcium-phosphate coatings; nanotubular 
titanium; self-assembled peptides; antimicrobial peptides
1. INTRODUCTION
Titanium and titanium alloys are widely used materials for dental and orthopedic implants 
due to their superior properties. 1–2 Nonetheless, they still face improper implant–tissue 
integration with the surrounding bone that often occurs due to unwanted biological 
responses, starting with bacterial colonization, then bacterial infection and, finally, fibrous 
capsule formation. The success of implants depends not only on the bone-implant 
integration, but also the prevention of bacterial infection. 3–4 Thus, bacterial infection and 
osteointegration are still major challenges in implantation. In all cases, biological response is 
related with the surface properties of implants; therefore, surface modifications are essential 
to enhance the biocompatibility, osteoconductivity, and antimicrobial properties of 
biomaterials. 4–5
To prevent bacterial infection, several surface modification strategies have been applied, 
besides conventional systematic antibiotic treatment, such as development of non-fouling 
surfaces, functionalization of surfaces with antibiotics, and biocidal substances. The 
effectiveness of each strategy depends on various parameters such as type of pathogen in 
case of creating non-fouling surfaces, spectrum of activity for the chosen antibiotic drug as 
well development of antibiotic resistance in a relatively short time period, and systemic 
toxicity for biocides because of high doses. 4, 6–7 Therefore, alternative strategies need to be 
developed.
There is a clear need for a broad-spectrum antimicrobial substance that prevents bacterial 
colonization on implant surfaces, minimizes bacterial resistance with displaying long-term 
stability and has a low cytotoxicity profile. Antimicrobial peptides have the potential to meet 
these criteria due to their superior microbiocidal characteristics and broad spectrum 
compared to synthetic and semi-synthetic antibiotics. 6, 8–10 AMPs are less likely to cause 
pathogen resistance and are thus very appealing. Although AMPs are promising candidate 
for the new generation of antimicrobial surfaces, 11–12 applications of AMPs are limited 
with their systemic well distribution. The problem in distribution of AMPs sometimes 
requires the use of high concentration of peptides that may bring toxicity problems. Their 
rapid protease digestion and peptide aggregation are also another challenge to utilize them as 
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systematic antimicrobial agents. They are also good candidates for local therapy to prevent 
bacterial infection at the implant site compare to convectional antibiotics. 4, 7, 13 AMPs 
would be an intriguing alternative instead of classical antibiotics without preventing bone 
growth at implant site and with their low toxicity profile. 14 Thus, stable immobilization of 
AMPs on implant surfaces could be the way to overcome all limitations with increasing their 
long-term stability and activity.1011–12, 15–18
Various covalent immobilization strategies that are based on chemical-coupling reactions 
have been applied for AMP immobilization on various materials such as metals including 
titanium 1920–22 polymeric brushes and resins 2324–25 and glass cover slips. 26 Among them, 
self-assembled monolayers (SAMs) of thiol- and silane-based molecules are widely used for 
biological surface modification of implant materials. However, they suffer as suitable 
functional molecular candidates applied onto nano- to micro-porous Ca-P coatings due to 
their limitation to apply over the surfaces with different topographies and stiffness as well as 
their surface chemistries. Their application requires the presence of functional groups, which 
are non-specific to surfaces and synthetic pathways, and it necessitates complex chemistry. 
They have also limited control on the orientation of the antimicrobial agent, which may 
restrict the agent’s ability to retain biological activity. Their applicability is also limited to a 
range of implantable materials specifically metal and metal oxides (i.e., titanium-based 
materials, gold, platinum and glass). 27
Ceramics and minerals are also one of the preferable materials in implantation. For example, 
the surface treatments of Ca-P based materials are also commonly used in dental and 
orthopedic applications due to their osteoconductive properties, and high loading capacity 
for antibiotics and antimicrobial agents. 28–31 Antibiotics however cannot be incorporated 
into the calcium phosphate coatings during its formation because of the extremely high 
processing temperature applied in plasma spraying. Moreover, physical absorption of the 
antimicrobial agents onto the surface of calcium phosphates limits the loaded amount and 
release characteristics. 28, 32–33 There is therefore a need to find new ways to functionalize 
Ca-P surfaces with functional groups to create antimicrobial surfaces.
Next generation molecular linkers in creating antimicrobial surfaces are expected to induce 
controlled and predictable interactions at bio-material interfaces with high material binding 
affinity and selectivity. These two properties can only be achieved with material surface 
recognition capability, which is necessarily specific to a desired surface. Having these 
properties may enable precise control of the density, the functionality and the accessibility of 
biomolecules. 34–35 During the last decade, material binding peptides possessing affinity and 
specificity to variety of inorganic surfaces have been generated using phage and cell surface 
display techniques. 36–37 Their potential use was increasingly demonstrated in various 
scientific disciplines including surface functionalization, 36, 38–40 biomineralization, 41–43 
tissue engineering 44 and regenerative medicine. 45 Application of surface-binding peptides 
to hard-tissue regeneration and restorative medicine is particularly intriguing and, 
consequently, there has been a great deal of interest in identifying and characterizing 
peptides that bind to various biocompatible materials, such as TiO2, Au, SiO2, 
hydroxyapatite (HA), and selected polymers. 38–40, 44, 46
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In the present study, an engineered chimeric peptide was designed as a self assembled 
antimicrobial bio agent against Escherichia coli (E. coli) and Streptococcus mutans (S. 
mutans) to apply over the micro-porous Ca-P minerals coated onto nano-tubular titanium. 
The chimeric peptide is engineered to combine both antimicrobial and hydroxyapatite-
binding peptide domains to achieve bioenabled self assembly of the peptide in a single step. 
HABP1 was previously discovered in our group using a combinatorial biology based phage-
display protocol. 41 This short peptide was synthesized in conjugation with an idealized 
AMP sequence through a triple glycine bridge. AMP motif, i.e. tet127 (KRWWKWWRR), 
was chosen from a study performed by Hilpert et al. 47 due to its high activity against 
Pseudomonas aeruginosa while covalently tethered on a substrate. This property makes the 
peptide very attractive to exhibit potent antimicrobial activity both in solution 48 as well as 
tethered form. 47 The efficiency of HABP1-AMP dual-functional was evaluated against E. 
coli and S. mutans in solution with a microdilution assay. Bacterial infection was next 
evaluated on the functionalized Ca-P coated nanotubular titanium surface with confocal 
microscopy (CM).
The proposed method eliminates complex surface functionalization procedures or the 
covalent modification of the implant surfaces that are coated with osteoconductive minerals. 
In a single step, bio-self assembly provides to combine the delivery of antimicrobial peptide 
over a Ca-P coatings deposited on metalic implants having any nano- to micro-scale 
features. The approach is general and applicable to various biomaterials and implants 
surfaces, and may be a candidate for the prevention of implant infections for diverse kinds of 
medical devices.
2. EXPERIMENTAL SECTION
2.1 Nanotubular Titanium Surface Preparation and Characterization
Sizes of 250 by 250 by 1 mm plates of commercially available pure titanium (cp grade) were 
incrementally ground utilizing #120 grit down to #1200 grit emery paper and wet polished in 
a one micrometer diamond paste, washed with distilled water and sonicated in acetone. The 
nanotubular titanium oxide surfaces were prepared in an electrochemical cell using a 
stainless steel cathode with an anodic constant voltage of 40 V in 0.5 wt % NH4F ethylene 
glycol solution at room temperature for 30 min. The total number of specimen was six. The 
crystalline structure and morphology of nanotubular surfaces were characterized using an X-
ray diffractometer (Philips PW 3710) and a field emission scanning electron microscopy 
(SEM, XL-30-FEG, FEI, The Netherlands; and JEOL JSM 7000F FEI, The Netherlands), 
respectively.
2.2 Calcium Phosphate Coating and Characterization
Nanotubular Titanium surfaces were bioactivated by immersion in 0.5 M NaOH for 2 min at 
50 °C and rinsed with deionized water to prevent crack-formation. A modified simulated 
body fluid, containing reagent grade 0.15 M NaCl, 1.67 mM K2HPO4 and 2.50 mM CaCl2, 
pH buffered at 7.2 with the addition of 0.05 M Tris(hydroxyl aminomethane) (pH 7.4) and 
hydrochloric acid, was used as the supporting electrolyte solution. All chemicals were 
reagent grade. Deposition was conducted in a typical three-electrode electrochemical cell. 
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The working electrode was the titanium sample, the reference electrode was a standard 
silver-silver chloride reference electrode (Ag/AgCl in saturated KCl) and the counter 
electrode was platinum. Deposition was carried out at 80 °C by pulsing the current density 
between −10 mA/cm2 for 0.2 sec and 10 μA/cm2 for 10 sec for 100 cycles and then 
maintaining at a constant cathodic current density of −10 mA/cm2 for 60 min. Coated 
samples were characterized using an X-Ray Diffractometer (Philips PW 3710) and a FT-IR 
Spectrometer (Mattson 1000). FE-SEM Crosssectional images of CaP coated samples were 
obtained by forming a groove on the back of coated subtrates, freeze-drying in liquid 
nitrogen for 30 sec and then mechanically breaking the substrate to expose the length of 
nanotubes. 49
2.3 Peptide Synthesis
Three different peptides (cHABP1, AMP, cHABP1-AMP) were synthesized by standard 
solid phase peptide synthesis technique on Wang resin (Novabiochem, San Diego, CA) using 
Fmoc chemistry CSBio 336s (CSBio Inc., Menlo Park, CA) automated peptide synthesizer 
and HBTU activation was used for the synthesis. The resulting resin-bound peptides were 
cleaved and side-chain-deprotected using Reagent K (TFA/thioanisole/H2O/phenol/
ethanedithiol (87.5:5:5:2.5)) and precipitated by cold ether. Obtained crude peptides were 
purified by RPHPLC up to a >98% purity (Gemini 10u C18 110A column). The purified 
peptides were checked by mass spectroscopy (MS) using a MALDI-TOF mass spectrometer.
2.4 Bacterial Maintenance and Culturing
Two different bacteria type, one gram-positive (Streptococcus mutans, ATCC® 25175™) 
and one gram-negative (Escherichia coli, ATCC® 25922™) were selected for measurement 
of antibacterial activity of newly designed dual-functional peptide. E. coli and S. mutans 
were cultured in LB (Luria Bertani) media and Brain Heart Infusion (Fluka, 53283) 
respectively and incubated at 37 °C with constant agitation (200 rpm) to proceed all 
experiments.
2.5 Broth Microdilution Antibacterial Assay for Free Peptides
The inhibition effect of the peptides in the presence of different concentrations was 
determined according to Broth Microdilution Antibacterial Assay of Peptides. Briefly, serial 
dilutions of the each peptide (from 1, 2, 4 μg/mL to 256 μg/mL) were prepared in double 
distilled water (ddH2O) in 96-well microliter plates. Two different bacteria inoculum (E. coli 
and S. mutans), which were diluted from overnight culture, were allowed to grow 
exponential phase then incubated with the peptides to determine minimum inhibitory 
concentration (MIC). A volume of 180 μL of test organism in proper media as described in 
previous section and 20 μL of peptide solutions at final concentrations of (from 1, 2, 4 μg/L 
to 256 μg/mL) were placed into 96-well plates and incubated at 37°C for 16 to 20 hours. 
Subsequently, growth inhibition was detected with spectrophotometric methods via optical 
density measurement at 600 nm. All experiments were repeated three times in duplicate for 
each bacterial strain.
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2.6 Peptide Surface Modification
Prior to surface modification experiments, a mild cleaning procedure was employed to the 
HA-coated titanium surfaces. All surfaces were washed with DI water several times 
followed by mild vortexing. Washed surfaces were then sterilized under UV light for 10 min. 
The surfaces were then incubated overnight with PC buffer (55 mM KH2PO4, 45 mM 
Na2CO3, 200 mM NaCl) containing 0.1% detergent (combination of 20% (w/v) tween 20 
and 20% (w/v) tween 80) for surface equilibration. To accomplish peptide-surface 
modification, surfaces were placed first in fresh buffer and then peptide solution was added 
to a 256 μg/mL final concentration in 1mL total volume. Finally, surfaces were incubated 
overnight at room temperature with constant rotating (80 rpm) to allow peptide-surface 
interaction.
2.7 Anti-adhesive Effect of Peptides
Bacterial adhesion characteristics of functionalized HA-coated titanium surface were 
evaluated against one gram-positive (S. mutans) and one gram-negative (E. coli) bacteria via 
cell spreading method. Briefly, both bacteria strains were cultured overnight in a proper 
media and conditions (as described above in bacterial strains section). A concentration of 
106 cells/mL from the overnight culture were inoculated into fresh media and incubated until 
mid-log growth phase. The cultures were then centrifuged at 2700 rpm for 10 min and the 
supernatants were discarded. The precipitated cells were first washed twice with PBS, and 
then resuspended in 1.0 mL PBS at a concentration of 107 cells/mL. Then, the bacterial 
suspension was exposed onto each peptidemodified surface in a 24 well plate and incubated 
for 24 hrs at 37 °C. The surfaces were removed from the wells with sterile forceps and 
gently washed with PBS. Subsequently, surfaces were placed in broth and the attached 
bacteria were dislodged by mild ultrasonication for 2 min in an ultrasonic bath followed by 
rapid vortexing (10 sec). Cell spreading method following serial tenfold dilutions was used 
to determine the number of bacteria on the surface.
2.8 Bactericidal Effect
The bacterial suspension (E. coli and S. mutans) as concentrated by centrifugation and 
resuspended in PBS at a concentration of 5 × 107 cfu/mL; 1 mL of the bacteria suspension 
was added to each substrate in 24-well plate. Slide chambers were covered and placed in a 
humidified incubator at 37 °C; after 2 hrs, nonadherent bacteria were removed with PBS. 
Adherent bacteria were stained with FITC (6 μg/mL) in PBS for 15 min at 37 °C. Slides 
were rinsed with PBS and visualized under confocal microscope (Leica TCS SP2 SE). 
Fluorescent (488-nm band-pass filter for excitation of FITC) images were taken at identical 
locations to determine stained with FITC.
2.9 Peptide Structure Generation
Structures of the peptides were generated with PyRosetta software using Robetta server 
library fragments and energy minimization routing. New structures were generated through 
Five hundred decoys for each peptide. The secondary structure features recorded for each 
generated structure were the lengths of the alpha helices, the lengths of turns and the lengths 
of bends. DSSP was used to calculate the secondary structure features based on the three-
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dimensional atomic positions for each generated structure. 50 Rules were induced by the 
Modified Learning from Experience Module version 2 (MLEM2). 50–51 The induced rules 
represent the secondary structure features that are specific to a single sequence among the 
three sequences (AMP, cHABP1, cHABP1-AMP) considered.
3. RESULTS
3.1 Titanium Surface Preparations and Characterization
FE-SEM image (Fig. 1) confirmed that the electrochemically treated pure titanium possessed 
orderly arrangements of nanotubular structures, with an average diameter of 90 nanometers 
and an average length of 2.5 – 3.0 micrometers. 48, 51, 52 The left inset is cross sectional 
view of the nanotubes and the right inset represents cross section of calcium phosphate 
deposition on nanotubular titanium.
3.2 Calcium Phosphate Coating on Titanium Surface and Its Characterization
FE-SEM of 2.4 – 3.2 micrometer thick CaP deposit on nanotubular titania confirmed the 
formation of a layer with uniformly distributed acicular crystals, approximately 150 nm in 
diameter, and 0.5 μm long, with Ca/P atomic ratios of 1.67 – 2.0 as shown in Fig. 2. The 
XRD spectrum (Fig. 2a) displayed the highest intensity peaks at 31.8º, 32.1º, and at 25º 
values of 2θ, typically observed in carbonated HA. 49, 52–53 The FTIR spectrum (Fig. 3b), 
displayed phosphate peaks at 520–660, 961, and at 976–1190 cm−1; peak for -OH bend at 
635 cm−1; peak for -OH stretch at 3650 cm−1, which confirms the presence of hydroxyl in 
the structure; and carbonate peaks at 875 and 1300–1650 cm−1. The hydroxyl peaks in 
carbonated HA were less prominent than those observed in HA. 52 The compound was thus 
characterized to be a biphasic HA (HA, Ca10(PO4)6(OH)2) and carbonated HA (CHA, 
Ca10(PO4)3(CO3)3(OH)2).
3.3 . Physiochemical Properties of Dual-Functional Peptides
Engineered dual-function peptide (cHABPI-AMP) has both material binding affinity to HA 
and high antimicrobial activity exhibiting simultaneously. Physicochemical characteristic 
and sequence information of peptides including the molecular weight (MW), isoelectric 
point (pI), charge and gravity values, which were calculated using the ExPASy prot-param 
tool of the Swiss Institute of Bioinformatics are listed in Table 1. The cHABPI demonstrated 
a low molecular weight (968.17) with no charge at pH 6.90. 41 HHC36/Tet 127, which is 
chosen from the literature, is a cationic peptide (charge of +5) with highest pI (12.31) 
compared to the other chosen peptides (Table 1), and has a wide antimicrobial spectrum. 
14, 54–55 The peptide, i.e.cHABP1-AMP, is designed to have a flexible –GGG-linker to 
provide enough flexibility for the peptide to ensure dual functionality. The dual-functional 
peptide demonstrated a cationic property (charge of +5), similar to the chosen AMP, but has 
lower pI value (10.93) compared to the AMP peptide (Table 1). The values of the 
hydropathy index of the each peptide were listed in Table 1 as GRAVY column. AMP has 
highly negative hydropathy index (−2.767), with high potential for disturbing the cell 
membranes. On the contrary, cHABP1 has positive hydropathy index (0.456) with partially 
inhibited bacterial reproduction. cHABP1-AMP has also negative hydropathy index 
(−1.048) with both functionalities. Although varieties in hydropathy index according to their 
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function, it is difficult to make parallel correlation in between hydropathy index and 
antimicrobial activity of peptides.
3.4 Broth Micro Dilution Antibacterial Assay for Antimicrobial Activity of DualFunctional 
Peptides.
Next, the inhibition effect of the peptides versus their varying concentration was determined 
according to Broth Micro dilution Antibacterial Assay. In this assay, 106 cfu/mL cells were 
incubated with peptides at various concentrations from 1 μg/mL to 256 μg/mL at 37 ºC for 
16 to 20 hrs. As shown in Fig. 4a and 4b, AMP (HHC36/tet127) had great activity against E. 
coli and S. mutans as reported in literature. 8, 14, 54–55 However, the trend of the 
antimicrobial activity is observed to be different in two bacterial conditions. The best 
working conditions of AMP is 32 μg/mL for E. coli (Fig. 4a), and 16 μg/mL for S. mutans 
(Fig. 4b). In the case of the dual functional peptide, cHABP1-AMP, it demonstrated an 
antimicrobial activity in solution but the antimicrobial activity is low compared to the 
positive control (AMP) against E. coli (Fig. 4a) and S. mutans (Fig. 4b) in solution, as 
expected. The minimum inhibitory peptide concentration for cHABP1-AMP against E. coli 
is 32 μg/mL (Fig. 4a), which is the same condition for AMP against to E. coli. In case of S. 
mutans, determination of the minimum inhibitory peptide concentration is difficult compare 
to that of E. coli. The sharp decrease in cHABP1-AMP absorbance as observed in the E. coli 
(Fig. 4a) was not observed with the increasing peptide concentration from 32 μg/mL to 256 
μg/mL against S. mutans (Fig. 4b). A complete bacteria inhibition was not observed at the 
highest cHABP1-AMP peptide concentration of 256 μg/mL (Fig. 4b). But, it is clear that the 
engineered peptide with dual functionality had a remarkable antibacterial activity in solution 
especially in the presence of E. coli (Fig. 4a). In addition, we have surprisingly observed 
cHABP1 partially inhibited bacterial reproduction as a negative control. Compared to only 
cHABP1, the number of cells for the dual functional peptide at higher concentrations of 
peptide (128 μg/mL and 256 μg/mL), in each type of bacteria conditions, were magnitudes 
of two times lower (Fig. 4a and 4b).
The antimicrobial activities of dual functional peptide were analyzed over a continuous 
bacterial growth for 16 hrs at the highest concentration (256 μg/mL) in the presence of E. 
coli and S. mutans (Fig. 5). Dual functional peptide (cHABPI-AMP) inhibits around 90 % 
and 75 % bacterial growth in case of E. coli and S. mutans, respectively (Fig. 5).
3.5 Antimicrobial efficacy of dual-function peptide on Ca-P coated Titanium Surface.
Bactericidal Effect—To examine the striking difference in bacterial adhesion between 
non-functionalized and peptide functionalized Ca-P coated nanotubular titanium surface, 
confocal microscopy experiments were performed. cHABP1-AMP on the surface 
antimicrobial activity was shown with confocal microscopy against S. mutans and E. coli 
(Fig. 6). cHABP1-AMP functionalized surface has better antimicrobial activity as shown in 
Fig. 6 against to S. mutans than E. coli.
Anti-adhesive Effect—Bacterial adhesion characteristic of functionalized substrates were 
assessed via plate spreading method at longer time period (24 hrs) for E. coli and S. mutans 
(Fig. 7). At the end of 24 hours incubation period, 30% decreases in bacteria number (S. 
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mutans) were approximately observed in the presence of cHABP1 and cHABP1-AMP 
compared to bare (non-functionalized surface). There is no significant difference among 
cHABP1 and cHABP1-AMP.
In case of E.coli at 24 hours, significant difference was observed among nonfunctionalized 
surface, cHABP1, cHABP1-AMP treated surface. 20% decrease for cHABP1 treated surface 
and 70% decrease for cHABP1-AMP treated surface were observed. This observation is 
correlated with in solution experiment. Dual functional peptide is more efficient for E. coli 
with low bacterial adhesion rate.
3.6 Secondary Structure Features
Which features of peptide backbone shapes are associated with each distinct level of 
antimicrobial efficacy are examples of structure-function relationships. The rule induction 
algorithm finds these relationships by prioritizing features according to the relevance to the 
antimicrobial activity level. 56–58 The rules found that covered at least 5–10% of the 500 
structures generated for one peptide are in Figure 8. Each rule specifies which secondary 
structures are observed with a specific antimicrobial level compared to all other observed 
antimicrobial levels. The secondary structures investigated are bends, turns and alpha 
helices. A bend is a backbone feature in which the backbone curvature is high. A turn 
describes a bend that has hydrogen bonding between backbone atoms. An alpha helix is a 
turn with a regular hydrogen-bonding pattern. In Figure 8, all of the rules are the same 
between the two studied pathogens because the relative order of effectiveness among all 
three peptides studied was the same for both pathogens. Depending on frequencies as 
indicated Figure 8, Rule 1 for AMP, Rule 4 and 5 for cHABP1-AMP, and Rule 6 for 
cHABP1. Figure 8 show the corresponding structures for each of the rules.
4. DISCUSSION
We have demonstrated dual-functional peptide-based approach to functionalize Ca-P coated 
titanium surface to inhibit bacterial spreading and to reduce bacterial adhesion. 
Functionalized surface has strong bactericidal effect on gram positive (S. mutans) and 
gramnegative (E. coli) bacteria. The peptide application method based on self-assembly 
process is simple and easy to apply for surface functionalization. Due to the method 
simplicity, the peptide solution can be applied for peri-implant infection immediately before 
the surgery. Simplicity of peptide application to implant material surface makes this peptide 
approach clinically feasible. Both implants and peptide solutions can be packaged and stored 
separately. The implant surface can be modified in the operating room before surgery and 
also can be used as washing solution during implant insertion in the body.
4.1 Surface Characteristics of Nanotubular Titanium and Ca-P coated Nanotubular 
Titanium.
The fabrication of TiO2 nanotubular structures by the anodization method has attracted wide 
interest because of their high surface-to-volume ratio, controllable dimensions, adjustable 
wettability, and simple processing procedures. 59–60 It has been reported that TiO2 nanotube 
arrays on titanium surfaces can significantly accelerate osteoblast cell growth and adhesion 
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in vitro 33 and improve bone formation and bonding strength in vivo. 61–62 In addition, since 
titania nanostructures are formed by the anodization of the titanium substrate itself, the 
coating has stronger mechanical adhesion than most bioceramic coatings (e.g. HA coating) 
processed by deposition techniques such as plasma spray, electrophoretic and electrolytic 
deposition. 49 Due to the ceramic high adhesion probability to nanotubular titanium, we 
applied Ca-P coated to the nanotubular titanium surface. Ca-P coatings have proven good 
effect on implant material biocompability and osteoconductivity. The presence of 
biologically active oxide layer and a stable crystalline base for Ca-P deposition, which are of 
critical importance in shaping the cellular interaction between the host tissue and implant, 
enabling transmission of forces and long term implant success. 5, 14, 49, 54, 63 On the other 
hand, Ca-P coatings by applying electrolytic deposition are good platform to deliver growth 
factors, and drugs due to the porous surface properties. This allows us to load more peptides 
to the implant materials by increasing surface area.
4.2 Designing of cHABP1-AMP Dual-Functional Peptides to Functionalize the Ca-P 
coated Nanotubular Titanium Surface
We have demonstrated material binding peptide-based immobilization methodology, which 
can be new approach for local delivery of antimicrobial agents at the implant site to prevent 
bacterial infection. The concerns regarding the local delivery of antibiotics in implantation is 
the relative inhibition of osteointegration and bacterial resistance to them. High doses of 
antibiotics often affect the cell viability and osteogenetic activity. AMPs are promising 
candidates due to the their potential bactericidal capability and low risk of developing 
antibiotic resistant pathogens. The AMP peptide (tet127/HHC36), which is chosen in this 
work, has been investigated for its antimicrobial performance and its effect in vivo bone 
growth on calcium phosphate coated implants. 14, 54–55
Extensive effort has been made to identify the antimicrobial mechanism of AMPs and 
surface associated AMPs. 6, 16–17 It has been previously showed that AMPs has great affinity 
negatively charged membranes of bacteria. They act through either permabilization of 
bacteria membrane or translocate across the bacterial membrane to attack cytoplasmic 
targets. 14, 47 Electrostatic interaction in between negatively charged outer layer of the 
bacterium and the positively charged AMP is the initial step for activity of AMPs. High local 
concentration of cationic peptides attached the bacterial membrane; dramatic change in 
bacterial surface electrostatics will be induced. 14, 64 The ability of AMPs to selectively 
interact with bacterial cells rather than the mammalian cells makes them preferable 
antimicrobial material. The major factor that contributes to selectivity property of AMPs is 
cationic property. The surface of bacterial membranes is more negatively charged than 
mammalian cells. This will lead to higher affinity of AMPs for bacterial surfaces. 54, 65 
Moreover, mammalian cell membranes contains high amount of cholesterol, which absent in 
bacteria cells, as membrane stabilizing agents and inhibitor of AMP activities. Nevertheless 
each type of AMPs has different cytotoxicity behavior against bacteria and mammalian cells.
In this work a dual functional peptide, GGG were chosen as a flexible linker to combine 
cHABP1 and AMP in one molecule. Due to the design of dual functional peptide, one side 
contains peptide (cHABP1) domain with cyclic structure. This restricts the some of 
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conformational movement in the dual–functional peptide. Therefore, the flexible linker may 
allow us separate two functional domains and gain more flexible movement ability to each 
domain.
As we discussed above, cationic properties of peptide enhance its antimicrobial activity. In 
this study designed dual-functional peptide and AMP has the same cationic charge. Thus the 
difference in their antimicrobial activity is not only related cationic properties of peptide but 
also various features as conformational properties which is difficult to determine then both 
on the surface and while interacting with the bacteria.
The cHABP1, which is pI is 6.90, has negative charge at pH 7.4. AMP and cHABP1-AMP 
has cationic charge and theoretical isoelectric point of 12.31 and 10.93 respectively. Such 
high isoelectric point makes two peptides highly positive at working pH (7.4) and provides 
numerous opportunities for positively charged Arg and Lys residues to interact with the 
bacteria membrane. Some of the studies also refer that cationic properties of AMP help 
interact with the negatively charged Ca-P surfaces because of negatively charged phosphate 
group. The referred interaction mainly based on electrostatic interaction. 14, 54 The 
interaction between peptide and material surfaces rely on not only electrostatic interactions 
between peptide and surface but also various parameters such as peptide conformation, 
peptide sequence, amino acid type, charge and its location in peptide. Thus peptide-surface 
interactions related completed and interrelated parameters, which is difficult to explain for 
each type of materials. 39, 44
4.3 Antimicrobial Activity of Dual-Functional Peptides in Solution.
In summary, all in solution activity cases; AMP is the most efficient antimicrobial activity at 
constant concentration compare with dual-functional counterpart and cHABP1. Dual-
functional peptide (cHABP1-AMP) has antimicrobial activity at certain concentrations 
against to S. mutans and E. coli. The results reveal that AMP is more efficient for S. mutans 
as a gram-positive bacterium compare to E. coli. Lowest peptide concentration is 16 μM and 
32 μM to inhibit the growth of S. mutans and E. coli respectively. The same trend was 
observed for each bacteria type in the presence of dual-functional peptide.
These results of AMP and it`s dual-functional molecular construct in solution may be 
compared with the information in the literature regarding the models on the AMP activity 
based on membrane properties of the gram-positive and the gram-negative bacteria. In 
general, the bacterial membranes are rich in the acidic phospholipids. Especially, the outer 
surface of Gram negative bacteria are composed of negatively charged lipopolysaccharides 
(LPS), which are held together by magnesium and calcium ions that bridge negatively 
charged phosphosugars. Addition of positively charged antimicrobial peptides results in 
displacement of divalent cations (Mg+2, Ca+2) that leads local distribution of outer 
membrane and promotes cell death. 66–67 Rely on the results in the literature; gram negative 
bacteria have faster permeabilization and killing kinetics respect to gram positive bacteria 
and this also confirm the conclusion of previous studies that double membrane of this gram 
negative bacterium is a less efficient barrier than the single membrane and thick 
peptidoglycan layer of the gram-positive species. 67–69
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Aside from bacterial membrane properties, AMP activity is not only controlled by 
membrane structure of the bacteria but also through gene regulation mechanism. This has 
been proposed to regulate selected resistance genes, e.g. dlt-operon, mprF and vraFG genes, 
when the bacteria come into contact with the AMPs. These specific genes mostly decrease 
the net negative charge of the envelope and limit the interaction of AMP with the envelope. 
66, 68–69 Although AMPs in solution activity is dependent on various parameters in solution, 
correlation of in solution parameters with on the surface ones is not understood yet.
4.4 Antimicrobial Activity of Dual-Functional Peptide On the Surface
The surface activity of dual functional peptides was evaluated at different time intervals, at 
long time periods (24 hours) in the presence of E. coli (gram-negative) and S. mutans (gram 
positive) (Figure 7). In solution antimicrobial activity indicate us AMP and the dual-
functional peptides were efficient for E. coli at 2X lower concentration compare to S. 
mutans. In solution and on the surface activity of AMP and dual functional peptides were 
different. For example AMP and dual functional peptide has high antimicrobial activity 
against to E. coli compare to S. mutans. This results reveal that antimicrobial properties of 
peptide on the surface not only depending on peptide charge. There are different parameters 
than peptide charge involved in antimicrobial activity. Conformation of peptide on the 
surface and available side chain of amino acids that can interact with the bacteria membrane 
can be crucial parameters.
On the other hand, cHABP1 has also antimicrobial activity. The charge of the peptide at pH 
7.4 is negative. This finding demonstrates that the antimicrobial activity cannot be related 
only charge of the peptide one more time. Other parameter such as conformation of peptide 
has a role in determining antimicrobial properties. Our peptide structure evaluations also 
emphasize the importance of the peptide structure to exhibit both mineral binding and 
antimicrobial property.
The results indicated above, antimicrobial activity of dual functional peptides is more 
pronounced in case of gram-positive bacteria (S. mutans) on the surface.
4.5 Structural Features of Peptides
In addition to the role of membrane structure properties and possible sensing mechanism of 
the bacteria in antimicrobial activity of AMPs, molecular structure of the peptides is also 
critical parameter that needs to be evaluated. Especially, designing new peptides with 
predictable ability for a specific material function is a current challenge in bioenabled 
material systems. Explicit structure-function relationships are progress toward this challenge 
because the effectiveness of candidate peptides is not obvious without experimental 
determination of the function level. Methods for evaluating candidate peptides before 
experimental determination make this challenge more tractable because the number of 
candidate peptides increase exponentially for every undetermined amino acid in a chimeric 
peptide. For maximum uncertainty about twelve amino acid positions, the number of 
candidates to be determined is more than 1015. The antimicrobial activity function 
relationships provide features to evaluate candidate peptides against before synthesizing 
them. According the observation shown in Figure 8, AMP fits to three of the rules having 
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alpha helix feature, which was not observed in the cHABP1-AMP peptide or cHABP1 
peptide structures 70. These results explain us the role of peptide structure as one parameter 
for the low antimicrobial efficacy of dual functional peptides. The antimicrobial features of 
dual functional peptides are strongly correlated with its structure. Therefore, structural 
features of dual functional peptides can be enhanced with new spacer designs for higher 
antimicrobial activity.
5. CONCLUSION
Calcium phosphate coatings are widely accepted for improved osteoconductivity at the 
metallic implant interfaces, which may accompanied with nanoscaled textures for improved 
osteointegration. Nevertheless, these surface modifications make even harder to deliver 
biological functional agents including antimicrobial peptides effectively at the implantation 
site. Here, we engineered a dual functional peptide that utilizes the biomolecular self-
assembly for local therapy to prevent bacterial infection at the implant material interface 
coated with a common bioceramic. To achieve this, calcium phosphate coating was 
successfully formed on nanotubular titanium by electrolytic deposition. The engineered 
peptide was self-assembled on the Ca-P coating in a single step process. Consequently, 
implant surface was found to significantly reduce the bacterial adhesion in the presence of 
gram-positive and gram-negative bacteria. In addition to our experimental analysis, our 
peptide structure function analyses also demonstrated that antimicrobial features of the 
engineered peptides are strongly correlated with their structures. Interestingly. AMP fits to 
three of the rules having alpha helix feature, which was not observed in the cHABP1-AMP 
peptide or cHABP1 peptide structures 70. These results explain us the role of peptide 
structure as one parameter for the low antimicrobial efficacy of dual functional peptides. The 
structure-function relationships may contribute to rational design of dual functional peptide 
with optimized biofunctionality. Due to the simplicity of the method, bioenabled approach 
can be used as self-assembled antimicrobial solution both prior and during the orthopedic 
surgery. The approach could be coupled with existing therapies and holds a promise by 
offering an alternative to fight against bacterial resistance and infection.
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HIGHLIGHTS
• Fabrication of nano-textured titanium surfaces coated with bioactive ceramics.
• Application of a chimeric peptide based self-assembly methodology on 
ceramic implants for local therapy.
• Easy to use self assembled antimicrobial solution both prior and during the 
orthopedic surgery.
• The approach could be coupled with existing therapies to fight bacterial 
infection.
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Figure 1: 
FE-SEM image of nanotubular titania (A) and (B) at different magnification.
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Figure 2: 
FE-SEM image of HA deposition on nanotubular titania at different magnification.
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Figure 3: 
HA deposition on nanotubular titania characterized by (A) XRD analysis, and by (B) FT-IR 
spectroscopy.
Yazici et al. Page 21
Mater Sci Eng C Mater Biol Appl. Author manuscript; available in PMC 2020 June 19.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
Figure 4: 
Broth Microdilution Assay (A) in the presence of E. coli and (B) in the presence of S. 
mutans incubated with peptides at 37°C for 16 hours
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Figure 5: 
The percentage of adherent E. coli (left) and S. mutans (right) after 16 hrs of the continuous 
bacterial growth in 256 μg/mL of AMP and cHABPI-AMP.
Yazici et al. Page 23
Mater Sci Eng C Mater Biol Appl. Author manuscript; available in PMC 2020 June 19.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
Figure 6: 
Confocal microscopy images of Ca-P coated titanium surfaces. (A) Bare and (B) cHABP1-
AMP functionalized after 2 hours incubation with S. mutans. (C) Bare and (D) cHABP1-
AMP functionalized after 2 hours incubation with E. coli.
Yazici et al. Page 24
Mater Sci Eng C Mater Biol Appl. Author manuscript; available in PMC 2020 June 19.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
Figure 7: 
Relative percentage of adherent bacteria on bare and functionalized surfaces (with cHABP1 
and cHABP1-GGG-AMP) at 24 hours in the presence of (A) E. coli, and (B) S. mutans.
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Figure 8: 
Characteristic secondary structures fitting each of the induction rules for AMP, cHABP1-
AMP, cHABP1 sequences. Induction rules for secondary structure features of AMP, 
cHABP1-AMP, cHABP1.
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Table 1.
Molecular characteristics of the engineered peptides (AMP, cHABP1, cHABP1-AMP).
Peptide Name Sequence MW
#
pI
#
GRAVY
#
Chr
#
AMP KRWWKWWRR 1487.78 12.31 −2.767 +5
cHABP1 CMLPHHGAC 968.17 6.90 0.456 0
cHABP1-Spacer-AMP CMLPHHGAC -GGG-KRWWKWWRR 2609.09 10.93 −1.048 +5
#
MW: Molecular Weight; pI: Isoelectric point; Chr: Net Charge and GRAVY: Grant Average Hydropathy Index (expassy.org)
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